Al-Quraishi, Z.; Ali-Jerman, H.; Laskar, P.; Muglikar, A.; Mackie, L.; Mullin, M.; Mackenzie, G.; Tate, R.J.; Hussain, M.; Perrie, Y.;
et al. Camptothecin-Bearing PEGylated Polypropylenimine Dendriplexes for Prostate Cancer Gene Therapy: Impact of Microfluidic Processing on Physicochemical Properties and Transfection. Pharmaceutics 2026, 18, 190.
https://doi.org/10.3390/pharmaceutics18020190
AMA Style
Al-Quraishi Z, Ali-Jerman H, Laskar P, Muglikar A, Mackie L, Mullin M, Mackenzie G, Tate RJ, Hussain M, Perrie Y,
et al. Camptothecin-Bearing PEGylated Polypropylenimine Dendriplexes for Prostate Cancer Gene Therapy: Impact of Microfluidic Processing on Physicochemical Properties and Transfection. Pharmaceutics. 2026; 18(2):190.
https://doi.org/10.3390/pharmaceutics18020190
Chicago/Turabian Style
Al-Quraishi, Zainab, Hawraa Ali-Jerman, Partha Laskar, Ashish Muglikar, Logan Mackie, Margaret Mullin, Graeme Mackenzie, Rothwelle J. Tate, Muattaz Hussain, Yvonne Perrie,
and et al. 2026. "Camptothecin-Bearing PEGylated Polypropylenimine Dendriplexes for Prostate Cancer Gene Therapy: Impact of Microfluidic Processing on Physicochemical Properties and Transfection" Pharmaceutics 18, no. 2: 190.
https://doi.org/10.3390/pharmaceutics18020190
APA Style
Al-Quraishi, Z., Ali-Jerman, H., Laskar, P., Muglikar, A., Mackie, L., Mullin, M., Mackenzie, G., Tate, R. J., Hussain, M., Perrie, Y., & Dufès, C.
(2026). Camptothecin-Bearing PEGylated Polypropylenimine Dendriplexes for Prostate Cancer Gene Therapy: Impact of Microfluidic Processing on Physicochemical Properties and Transfection. Pharmaceutics, 18(2), 190.
https://doi.org/10.3390/pharmaceutics18020190
